Extracellular matrix mineralization or calcification occurs in many pathologic conditions, including atherosclerosis, medial wall calcification, diffuse idiopathic skeletal hyperostosis, and chondrocalcinosis. Vascular wall calcification is the most common and involves two mechanisms: passive calcification resulting from breakdown of the protection system and active calcification resulting from transdifferentiation of mesenchymal cells in the vascular wall to bone. Although reports are conflicting, several matrix proteins are identified as protective factors against dystrophic calcification in nonosseous tissues. Serum matrix Gla protein may be a marker of osteometabolic syndromes that cause hyperostosis and plays a role in Milwaukee shoulder syndrome.

Calcium Deposition and Associated Chronic Diseases (Atherosclerosis, Diffuse Idiopathic Skeletal Hyperostosis, and Others) / F. Atzeni, P. Sarzi-Puttini, M. Bevilacqua. - In: RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. - ISSN 0889-857X. - 32:2(2006 May), pp. 413-426.

Calcium Deposition and Associated Chronic Diseases (Atherosclerosis, Diffuse Idiopathic Skeletal Hyperostosis, and Others)

F. Atzeni;P. Sarzi-Puttini;
2006

Abstract

Extracellular matrix mineralization or calcification occurs in many pathologic conditions, including atherosclerosis, medial wall calcification, diffuse idiopathic skeletal hyperostosis, and chondrocalcinosis. Vascular wall calcification is the most common and involves two mechanisms: passive calcification resulting from breakdown of the protection system and active calcification resulting from transdifferentiation of mesenchymal cells in the vascular wall to bone. Although reports are conflicting, several matrix proteins are identified as protective factors against dystrophic calcification in nonosseous tissues. Serum matrix Gla protein may be a marker of osteometabolic syndromes that cause hyperostosis and plays a role in Milwaukee shoulder syndrome.
Matrix gla protein; smooth-muscle-cells; bone morphogenetic protein 2; stage renal-disease; growth-factor-I; vascular calcification; crystal deposition; deficient mice; risk-factors; tissue transglutaminase
Settore MED/16 - Reumatologia
mag-2006
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0889857X06000202-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 176.27 kB
Formato Adobe PDF
176.27 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/664541
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 40
social impact